Breast cancer is one of the biggest problems. The scientist has been working hard to find the exact reason behind it. This will help them to treat patients in a much better and effective way. According to a new research published in journal BMC Genomics provides an exclusive description of study conducted on triple negative breast cancer patients. This is an astonishing research that has led to a discovery of seven molecular markers that are big contributors in behaviour of triple negative breast cancers. The break through of this study is revealing total new insight into the disease.The lead researcher of the study, Professor Andrew Tutt, Director of Breakthrough Breast Cancer's Research Unit at King's College London, explains, “'We are pleased to have been able to shed more light on this complex group of diseases that we so desperately need to understand better to improve the outlook for our patients. This knowledge will help us to develop more personalised treatments for triple negative breast cancer patients and ultimately save more lives.”
No comments:
Post a Comment